Predicting response to rifaximin in irritable bowel syndrome with diarrhea: Is the answer blowing in the wind?

Irritable bowel syndrome (IBS) is one of the most common functional bowel disorder worldwide (Clin Gastroenterol Hepatol 2012;10:712-721). The diagnosis is based on a patient reporting a specific combination of symptoms, as defined by the Rome criteria: abdominal pain, which is related to defecation, associated with a change in stool frequency or form (Gastroenterology 2016;150:1393-1407). IBS is further sub-grouped dependent on predominant stool form, be that diarrhea (IBS-D), constipation (IBS-C), or mixed stool pattern (IBS-M).

Source: Gastroenterology - February 13, 2020 Category: Gastroenterology Authors: Christopher J. Black, Alexander C. Ford Source Type: research